Genes may determine how much DNA damage smoking and other exposures cause, study finds
A new study has provided the first direct evidence that a person's inherited genes can influence how much DNA damage builds up after exposure to cancer-causing agents such as cigarette smoke or sunlight. The findings may help explain why some lifelong smokers never develop lung cancer, while some non-smokers do.
The research, published in Nature, suggests that inherited genetic differences shape not only the risk of developing cancer but also how cancers evolve after DNA damage occurs.
To investigate this, researchers bred four genetically distinct strains of mice with different natural susceptibilities to liver cancer. The animals represented a level of genetic diversity similar to that seen in humans.
Each mouse received the same dose of the cancer-causing chemical diethylnitrosamine (DEN) at 15 days of age. DEN is found in tobacco smoke and certain processed foods and is known to damage DNA in liver cells.
Because every mouse experienced identical exposure under controlled conditions, researchers were able to eliminate lifestyle and environmental differences that often make human studies difficult to interpret.
The team then analyzed nearly 600 liver tumors, sequencing their genomes and studying gene activity to reconstruct how each cancer developed.
They found that tumors across all mouse strains almost always developed mutations that activated the MAPK signaling pathway, a key driver of cell growth and many cancers.
However, genetic background strongly influenced what happened next. Depending on the inherited genes of each mouse, tumors accumulated different patterns of mutations, activated additional cancer-related pathways, and often developed whole-genome duplication—a process in which cells gain an extra copy of all their chromosomes, creating additional genetic material that can acquire further mutations.
Although the study was conducted in mice, the results suggest that inherited genetic differences could play an important role in determining individual cancer risk in humans.
REFERENCE: Aitken, S.J., Connor, F., Feig, C. et al. Genetic background sets the trajectory of experimental cancer evolution. Nature (2026). https://doi.org/10.1038/s41586-026-10821-z
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.